Treatment of refractory malignant lymphomas with ifosfamide/etoposide combination chemotherapy

Rationale for the use of alternating non-cross-resistant chemotherapy.

Goldie Jh, Coldman Aj, Gudauskas Ga · PubMed · 1982 · 550 citations

Medicine, Oncology, Pharmacology +10

Natural history of Hodgkin's disease as related to its pathologic picture

Robert J. Lukes, James J. Butler, Ethel B. Hicks · Cancer · 1966 · 504 citations · Full text

Medicine, Pathology, Cellular Pathology +11

Therapeutic trials with VP-16-213 and VM-26: active agents in small cell lung cancer, non-Hodgkin's lymphomas, and other malignancies.

Radice Pa, Bunn Pa, DC Ihde · PubMed · 1979 · 144 citations

Medicine, Oncology, Pharmacology +13

Efficacy of ifosfamide in refractory malignant diseases and uroprotection by mesna: results of a clinical phase II-study with 151 patients

M. E. Scheulen, N. Niederle, Karl Bremer et al. · Cancer Treatment Reviews · 1983 · 79 citations

Medicine, Oncology, Pharmacotherapy +3

Isophosphamide therapy for hematologic malignancies in patients refractory to prior treatment.

V. Rodríguez, K. B. McCredie, Michael J. Keating et al. · PubMed · 1978 · 48 citations

Medicine, Hematology, Oncology +15